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Eicosapentaenoicacidanddocosahexaenoicacid(EPA/DHA),n-3polyunsaturatedfattyacids(PUFAs),haveavarietyofbiological
activities includinganti-inﬂammatoryand anticancer eﬀects. We hypothesized that their peroxidized products contributed in part
to anti-inﬂammatory eﬀects. In the liver, the production of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) has
been implicated as one of the factors in hepatic inﬂammation and injury. We examined whether the peroxidation of EPA/DHA
inﬂuences the induction of iNOS and NO production in proinﬂammatory cytokine-stimulated cultured hepatocytes, which is
in vitro liver inﬂammation model. Peroxidized EPA/DHA inhibited the induction of iNOS and NO production in parallel with
the increased levels of their peroxidation, whereas unoxidized EPA/DHA had no eﬀects at all. Peroxidized EPA/DHA reduced the
activationoftranscriptionfactor,NF-κB,andtheexpressionoftheiNOSantisensetranscript,whichareinvolvediniNOSpromoter
transactivation(mRNAsynthesis)anditsmRNAstabilization,respectively. Theseﬁndingsdemonstratedthatperoxidized products
of EPA/DHA suppressed the induction of iNOS gene expression through both of the transcriptional and posttranscriptional steps,
leading to the prevention of hepatic inﬂammation.
1.Introduction
Accumulated evidence indicates that eicosapentaenoic acid
and docosahexaenoic acid (EPA/DHA), which are n-3
polyunsaturatedfattyacids(PUFAs)andareabundantinﬁsh
oil,haveavarietyofbiologicalactivitiessuchasantioxidative,
anti-inﬂammatory, and anticancer eﬀects. We previously
reported the anti-inﬂammatory and anticancer eﬀects of
various PUFAs both in vivo and in vitro [1, 2]. However, the
underlying mechanisms remain to be elucidated.
Since n-3 PUFAs are peroxidized spontaneously in the
air, it cannot negate the possibility that their peroxidized
products are involved partly in anti-inﬂammatory and
anticancer eﬀects. In fact, several studies demonstrated that
theanticancereﬀectofPUFAsdependedontheirperoxidized
levels[3–5].Sethi[6]reportedthatanti-inﬂammatory eﬀects
of n-3 PUFAs were due to their peroxidized products. Sethi
et al. [7] showed that peroxidized EPA diminished the
upregulation of endothelial cell adhesion molecules such
as VCAM-1 and ELAM-1 through the inhibition of NF-
κB activation in lipopolysaccharide- (LPS-) or cytokine-
stimulated human umbilical vein endothelial cell, while
unoxidized EPA had no eﬀect. Sethi and coworkers also
demonstrated that peroxidized EPA inhibited the expression
of chemokines such as monocyte chemoattractant protein-
(MCP-) 1 and interleukin (IL-) 8 in cytokine-stimulated
endothelial cells [8, 9].
In addition to such adhesion molecules and cytokines,
the production of nitric oxide(NO)by inducible nitric oxide
synthase (iNOS) has been implicated as one of the factors2 Journal of Nutrition and Metabolism
in liver inﬂammation and injury. Khair-El-Din et al. [10]
reported that DHA inhibited iNOS induction in interferon-
γ plus LPS-stimulated macrophages, although they did not
determine the levels of peroxidized DHA.
In animal models of liver injury caused by ischemia-
reperfusion, partial hepatectomy, and endotoxin shock, the
induction of iNOS and NO production is upregulated
concomitantly with the production of cytokines including
IL-1β, tumor necrosis factor-α, IL-6, and interferon-γ in the
liver, as we reported previously [11–15]. In these studies,
drugsshowing liver-protectiveeﬀectsinhibitedtheinduction
of iNOS and NO production as well as the decreased pro-
duction of various inﬂammatory mediators. Furthermore,
we have found that these drugs inhibited the induction
of iNOS, followed by the reduction of NO production
in proinﬂammatory cytokine-stimulated hepatocytes [13,
16, 17], which were used as a simple in vitro model of
liver inﬂammation for in vivo animal models. Thus, the
prevention of NO production is considered to be one of
the indicators of anti-inﬂammatory eﬀects. In this study, we
examined whether the peroxidation of EPA/DHA inﬂuences
iNOS induction and NO production in the primary cultures
of rat hepatocytes stimulated by IL-1β, and if so, what is the
mechanism involved?
2.Materialsand Methods
2.1. Materials. EPA and DHA (EPA/DHA) were purchased
from Nacalai Tesque (Kyoto, Japan). Recombinant human
IL-1β (2 ×107 U/mg protein) was provided by Otsuka Phar-
maceuticalCo.,Ltd.(Tokushima, Japan). [γ-32P]Adenosine-
5 -triphosphate (ATP; −222TBq/mmol) was obtained from
DuPont-New England Nuclear Japan (Tokyo, Japan). Rats
were kept at 22◦C under a 12h/12h light/dark cycle and
received food and water ad libitum. All animal experiments
were performed in accordance with the Guidelines for
the Care and Use of Laboratory Animals of the National
Institutes of Health and approved by the Animal Care
Committee of Kansai Medical University.
2.2. Primary Cultures of Hepatocytes. Hepatocytes were
isolated from male Wistar strain rats (200–300g; Charles
River, Tokyo, Japan) by collagenase (Wako Pure Chemicals,
Osaka, Japan) perfusion [18, 19]. Isolated hepatocytes
were suspended in culture medium at 6 × 105 cells/mL,
seeded into 35mm plastic dishes (2mL/dish; Falcon Plas-
tic, Oxnard, CA, USA), and cultured at 37◦Ci naC O 2
incubator under a humidiﬁed atmosphere of 5% CO2
in air. The culture medium was Williams’ medium E
(WE) supplemented with 10% newborn calf serum, Hepes
(5mM), penicillin (100U/mL), streptomycin (0.1mg/mL),
dexamethasone (10nM), and insulin (10nM). After 5h, the
medium was replaced by fresh serum- and hormone-free
WE, and the cells were cultured overnight before use in
experiments. The numbers of cells attached to the dishes
were calculated by counting the nuclei [20]a n du s i n gar a t i o
of 1.37 ± 0.04nuclei/cell (mean ± SE, n = 7 experiments).
2.3. Preparation of Peroxidized EPA/DHA. EPA/DHA were
dilutedintodimethylsulfoxide(DMSO)ataconcentrationof
300 mM and stored at −80◦Cu n d e rN 2 before experiments
(unoxidized EPA/DHA). For peroxidation, EPA/DHA were
treated under the air at 37◦C with a block incubator
for 1–3 days. Unoxidized or peroxidized EPA/DHA were
dissolved into WE medium at a ﬁnal concentration of
500μM (DMSO concentration was 20mM). Peroxidation
levels of EPA/DHA were measured by thiobarbituric acid
reactive substances (TBARSs) assay, using TBARS Assay Kit
(Cayman Chemical, Ann Arbor, MI, USA) according to the
instruction. Peroxidation levels of EPA/DHA were expressed
as malondialdehyde (MDA) concentration equivalent, which
is a typical of lipid peroxidized products.
2.4. Treatment of Cells with EPA/DHA. On day 1, the cells
were washed with fresh serum- and hormone-free WE, and
incubated with IL-1β (1nM) in the same medium in the
presence or absence of EPA (500μM) orDHA (500μM) with
various peroxidized levels. Peroxidation times and levels of
EPA/DHA used are indicated in the appropriate ﬁgures and
their legends.
2.5. Determinations ofNO Productionand LactateDehydroge-
nase (LDH). Culturemediumwas used formeasurements of
nitrite (a stable metabolite of NO) to reﬂect NO production
by the Griess method [21] and LDH activities to reﬂect cell
viability using a commercial kit (Wako Pure Chemicals).
2.6. Western Blot Analysis. Total cell lysates were obtained
from cultured cells as described previously [16] with minor
modiﬁcations as follows. Cells (1 × 106 cells/35-mm dish)
were lysed in 100–200μL of solubilizing buﬀer (10mM Tris-
HCl, pH 7.4, containing 1% Triton X-100, 0.5% Nonidet P-
40,1mMEDT A,1mMEGT A,phosphataseinhibitorcock-
tail (Nacalai Tesque), 1mM phenylmethylsulfonyl ﬂuoride
(PMSF), and protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany, passed through a 26-gauge needle,
allowed to stand on ice for 30min and then centrifuged
(16,000×g for 15min). The supernatant (total cell lysate)
was mixed with sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) sample buﬀer (ﬁnal: 125mM
Tris-HCl, pH 6.8, containing 5% glycerol, 2% SDS and
1% 2-mercaptoethanol), subjected to SDS-PAGE and elec-
troblotted onto a polyvinylidene diﬂuoride membrane (Bio-
Rad, Hercules, CA, USA). Immunostaining was performed
using primary antibodies against mouse iNOS (Aﬃnity
BioReagents, Golden, CO, USA), human phospho-IκBα
(Ser32/36 (5A5); Cell Signaling, Beverly, MA, USA), human
IκBα,h u m a nI κBβ, mouse type I IL-1 receptor (IL-1RI)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and rat
β-tubulin (internal control; Clone TUB2.1; Sigma Chemical
Co., St. Louis, MO, USA), followed by visualization with an
ECL blotting detection reagent (GE Healthcare Biosciences
Corp., Piscataway, NJ, USA).
2.7. Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR). Total RNA was extracted from cultured hepato-
cytes using a guanidinium-phenol-chloroform method [22]Journal of Nutrition and Metabolism 3
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Figure 1: Peroxidation of EPA/DHA. EPA (open circles) and DHA
(closed squares) were incubated under the air at 37◦Cf o rt h e
indicated times. Peroxidation levels of EPA/DHA were measured by
TBARS assay,and were expressed as MDA concentrationequivalent
per EPA/DHA (500μM). Data are means of 3 experiments.
with Trizol reagent (Invitrogen, Carlsbad, CA, USA) or a
phenol-free, ﬁlter-based totalRNAisolationkit(RNAqueous
Kit; Ambion, Austin, TX, USA) according to the manu-
facturer’s instructions, and then treated with a TURBO
DNA-free Kit (Ambion) if necessary. For strand-speciﬁc
RT-PCR analysis, cDNAs were synthesized from total
RNA with strand-speciﬁc primers, and step-down PCR
was performed using PC708 (Astec, Fukuoka, Japan), as
previously described [23, 24] with minor modiﬁcations.
For iNOS, IL-1RI and elongation factor-1α (EF; inter-
nal control) mRNAs, an oligo (dT) primer was used
f o rR Ta n dt h ep r i m e rs e t s5  -CCAACCTGCAGGTCT-
TCGATG-3  and 5 -GTCGATGCACAACTGGGTGAAC-3 
(257-bp product), 5 -CGAAGACTATCAGTTTTTGGAAC-
3  and 5 -GTCTTTCCATCTGAAGCTTTTGG-3  (327-bp
product), and 5 -TCTGGTTGGAATGGTGACAACATGC-
3  and 5 -CCAGGAAGAGCTTCACTCAAAGCTT-3  (307-
bp product) were used for PCR, respectively. For the
antisense transcript of iNOS, the sense primer 5 -CCT-
TTGCCTCATACTTCCTCAGA-3  was used for RT and
the primer set 5 -ACCAGGAGGCGCCATCCCGCTGC-3 
and 5 -ATCTTCATCAAGGAATTATACACGG-3  (211-bp
product) was used for PCR. The PCR protocols for iNOS
and EF, or IL-1RI were 10 cycles of (94◦C, 1min; 72◦C,
2min), 15 cycles of (94◦C, 1min; 65◦C, 1min 30s; 72◦C,
20s), and 5, or 15 cycles of (94◦C, 1min; 60◦C, 1min 30s;
72◦C, 20s), respectively. The PCR protocol for the antisense
transcript was 10 cycles of (94◦C, 1min; 65◦C, 1min 30s;
72◦C, 20s), 15 cycles of (94◦C, 1min; 60◦C, 1min 30s;
72◦C, 20s), and 5 cycles of (94◦C, 1min; 55◦C, 1min 30s;
72◦C, 20s). The ampliﬁed products were analyzed by 3%
agarose gel electrophoresis with ethidium bromide, and the
levels of iNOS, IL-1RI, EF, and antisense transcript were
semiquantiﬁed using a UV transilluminator. The cDNAs for
the rat iNOS mRNA and antisense transcript were deposited
in DDBJ/EMBL/GenBank under Accession nos. AB250951
and AB250952, respectively.
2.8. Electrophoretic Mobility Shift Assay (EMSA). Nuclear
extracts were prepared according to Schreiber et al. [25]wi t h
minor modiﬁcations [26]. Brieﬂy, the dishes were placed on
ice, washed with Tris-HCl-buﬀered saline, harvested with
the same buﬀer using a rubber policeman and centrifuged
(1,840×g for 1min). The precipitate (2 × 106 cells from
two 35-mm dishes) was suspended in 400μLo fl y s i s
buﬀer (10mM Hepes, pH 7.9, 10mM KCl, 0.1mM EDTA,
0.1mM EGTA, 500U/mL trasylol, 0.5mM PMSF, and 1mM
dithiothreitol) and incubated on ice for 15 min. After
addition of NonidetP-40 (ﬁnal: 0.625%), the cells were lysed
by vortexing (2-3 times for 1min each) and centrifuged
(15,000×g for 1min). The nuclear pellet was resuspended
with extraction buﬀer (10 mM Hepes, pH 7.9, 0.4 M NaCl,
0.1 mM EDTA, 0.1 mM EGTA, 500U/mL trasylol, 0.5mM
PMSF, and 1 mM dithiothreitol), followed by continuous
mixing for 20min and centrifugation (15,000×gf o r5m i n ) .
Aliquots of the supernatant (nuclear extract) were frozen
in liquid nitrogen and stored at −80◦C until use. Bind-
ing reactions (total: 15μL) were performed by incubating
nuclear extract aliquots (4μg of protein) in reaction buﬀer
(20mM Hepes, pH 7.9, 1mM EDTA, 60mM KCl, 10%
glycerol and 1mg of poly(dI-dC)) with the probe (approx-
imately 40,000dpm) for 20min at room temperature. In
the case of competitor assays, the nuclear extracts were
preincubatedinthe presenceofcoldprobes(250-foldexcess)
for 30min at 4◦C. The products were electrophoresed at
100V in a 4.8% polyacrylamide gel in high ionic strength
buﬀer (50mM Tris-HCl, 380mM glycine, 2mM EDTA, pH
8.5) and the dried gels were analyzed by autoradiography.
An NF-κB consensus oligonucleotide (5 -AGTTGAGGGGA-
CTTTCCCAGGC-3 ) from the mouse immunoglobulin κ
light chain was purchased (Promega, Madison, WI, USA)
and labeled with [γ-32P] ATP and T4 polynucleotide kinase.
The protein concentration was measured by the method of
[27] with a binding assay kit (Bio-Rad) using bovine serum
albumin as a standard.
2.9. Statistical Analysis. The results shown in the ﬁgures are
representative of 3-4 independent experiments yielding sim-
ilar ﬁndings. Diﬀerences were analyzed by the Bonferroni-
Dunn test, and values of P<. 05 were considered to indicate
statistical signiﬁcance.
3.Results
3.1. Peroxidized EPA/DHA Inhibit the Production of NO
in Hepatocytes. Figure 1 depicts the peroxidation levels of
EPA/DHAfor1–3days.The peroxidationlevelsofEPA/DHA
increased to 2–7μM of MDA time dependently, which are
near the ranges seen in the plasma of human (1.5–3.5μM
of MDA) fed ﬁsh oil diets [8, 28]. A proinﬂammatory
cytokine, IL-1β, stimulates the induction of iNOS, which
is followed by the production of NO in primary cultured
rat hepatocytes [29, 30]. Simultaneous addition of perox
dized EPA (500μM) or DHA (500μM) with IL-1β decreased4 Journal of Nutrition and Metabolism
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Figure 2: Eﬀects of peroxidized EPA/DHA on the production of NO. Cultured hepatocytes were treated with IL-1β (1nM) in the presence
or absence ofperoxidized EPA (a) andDHA (b) (each, 500μM) for10h. The levels of nitrite were measured in the culture medium (data are
means ± SD for n = 3 dishes/point; ∗P<. 05 versus IL-1β alone).
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Figure 3: Eﬀects of peroxidized EPA/DHA on cellular cytotoxicity.
Cells were treated with IL-1β (1nM) in the presence or absence
of peroxidized EPA and DHA (each, 500μM) for 10h. The LDH
activities were measured in the culture medium (data are means ±
SD for n = 3 dishes/point).
the levels of NO production (nitrite, NO metabolite) in
peroxidation-dependent manners (Figures 2(a) and 2(b)).
Neitherunoxidized EPA norDHAinﬂuencedtheproduction
of NO. Furthermore, an addition of MDA (2.5–10μM) with
IL-1β had no eﬀect on NO production (data not shown).
Peroxidized EPA/DHA had no cellular cytotoxicity, since
they showed no signiﬁcant increases of released LDH in the
culture medium (Figure 3)a n dh a dn oe ﬀect on Trypan blue
exclusion by hepatocytes (data not shown).
Figure 4 shows the correlation between peroxidation
level of EPA/DHA and suppression of NO production. The
correlationswerewell expressedasexponentialfunctionwith
high R2 value. From these results, we obtained the equations
y = 28.233e−0.3016x
R2 = 0.9522
y = 31.651e−0.2634x
R2 = 0.9939
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Figure4:Correlationbetween peroxidationlevelsofEPA/DHA and
inhibition of NO production. Cells were treated with IL-1β (1nM)
in the presence or absence of peroxidized EPA (open circles) and
DHA (closed squares) (each, 500μM) for 10h. Peroxidation levels
of EPA/DHA, μM of MDA concentration equivalent per EPA/DHA
(500μM); production of NO, nmole of nitrite/106 cells in the
culture medium.
as follows.
In case of EPA, N = N0e−0.3T,
N/N0 (NO inhibitory rate) = e−0.3T,
T = 3.3log(N0/N),
in case of DHA, N = N0e−0.26T,
N/N0 (NO inhibitory rate) = e−0.26T,
T = 3.8log(N0/N),
where N0 means NOconcentration with IL-1β, N means NO
concentration with IL-1β and peroxidized EPA/DHA, and T
means peroxidation levels of EPA/DHA.Journal of Nutrition and Metabolism 5
EPA
IL-1β (1nM)
Peroxidation (day)
−
−
−
−−
++ +
−
+
−
− +
+ +
+ +
+ +
+
+
0
20
40
60
80
100
i
N
O
S
(
a
.
u
.
)
iNOS
(130kD)
β-tubulin
(55kD)
∗
0123− 0123
EPA/DHA (500μM)
DHA
0
20
40
60
80
100
i
N
O
S
(
a
.
u
.
)
iNOS
(130kD)
β-tubulin
(55kD)
∗
∗
Figure 5: Eﬀects of peroxidized EPA/DHA on the expression of iNOS protein. Cells were treated with IL-1β (1nM) in the presence or
absence of peroxidized EPA and DHA (each, 500μM) for 6h. Cell lysates (25μg of protein) were subjected to SDS-PAGE in a 7.5% gel, and
immunoblotted with an anti-iNOS or anti-β-tubulin antibody. The bands corresponding to iNOS were quantitated by densitometry, and
the levels of iNOS were normalized by those of β-tubulin (lower, mean ± SD, n = 3 experiments; ∗P<. 05 versus IL-1β alone).
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Figure 6: Eﬀects of peroxidized EPA/DHA on the time course of NO production. Cells were treated with IL-1β (1nM) in the presence or
absence of peroxidized EPA for 3 days (a) and DHA for 1.5 days (b) (each, 500μM) for the indicated times (IL-1β,o p e nc i r c l e s ;I L - 1 β +
EPA or DHA, ﬁlled circles; EPA or DHA, ﬁlled triangles; controls (without IL-1β and EPA/DHA), open triangles). The levels of nitrite were
measured in the culture medium (data are means ± SD for n = 3dishes/point; ∗P<. 05 versus IL-1β alone).
3.2. Peroxidized EPA/DHA Inhibit the Induction of iNOS in
Hepatocytes. Western blotting analysis revealed that peroxi-
dized EPA/DHA also inhibited the expression of iNOS pro-
teininperoxidation-dependentmanners(Figure 5).Next,we
examined the following experiments with peroxidized EPA
for 3 days or DHA for 1.5 days, containing similar levels of
MDA (approximately 2-3μM), to elucidate the mechanisms
involved in their inhibitory eﬀects on NO production.
In cultured hepatocytes, the production of NO appeared
at 4-5h after IL-1β treatment and increased thereafter.
Simultaneous addition of peroxidized EPA/DHA signiﬁ-
cantly reduced NO production time dependently (Figures
6(a) and 6(b)). Experiments with Western blotting revealed
that peroxidized EPA/DHA decreased the levels of iNOS
protein (Figure 7), where peroxidized EPA/DHA markedly
inhibited the expression of iNOS protein at earlier time
periods(4–6h)butreducedtheirinhibitory eﬀectsthereafter
(8–10h). In experiments with RT-PCR, there was a similar
tendencyintheirinhibitoryeﬀectsontheexpressionofiNOS
mRNA (Figure 8), indicating that peroxidized EPA/DHA6 Journal of Nutrition and Metabolism
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Figure 7: Eﬀects of peroxidized EPA/DHA on the time course of iNOS protein expression. Cells were treated with IL-1β (1nM) in the
presence orabsence of peroxidized EPA for3 daysand DHA for 1.5days(each, 500μM) fortheindicated times.Cell lysates(25μgofp r ot e in)
were subjected to SDS-PAGE in a 7.5% gel, and immunoblotted with an anti-iNOS or anti-β-tubulin antibody. The bands corresponding to
iNOSwerequantitatedbydensitometry, andthelevelsofiNOSwerenormalizedbythoseofβ-tubulin (lower,mean ±SD,n = 3experiments;
∗P<. 05 versus IL-1β alone).
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Figure8:Eﬀects ofperoxidized EPA/DHAontheexpressionofiNOSmRNA.Cellsweretreated withIL-1β (1nM)inthe presence orabsence
of peroxidized EPA for 3 days and DHA for 1.5 days (each, 500μM) for the indicated times. Total RNA was analyzed by strand-speciﬁc RT-
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suppressed the induction of iNOS gene expression at a
transcriptional and/or posttranscriptional step.
3.3. Eﬀects of Peroxidized EPA/DHA on NF-κB Activation and
iNOS Antisense Transcript. We examined the mechanism
involved in the inhibition of iNOS mRNA expression by
peroxidized EPA/DHA. IL-1β stimulates a rapid phospho-
rylation and subsequent degradation of inhibitory proteins
of NF-κB( I κBα and IκBβ), followed by the activation of
transcription factor NF-κB. NF-κB is critical for the induc-
tion of iNOS gene expression through the transactivation of
iNOS promoter [16, 26]. EMSA revealed that peroxidized
EPA/DHA inhibited NF-κB activation (its nuclear translo-
cation and DNA binding) (Figure 9). However, peroxidized
EPA/DHA had no eﬀects on the phosphorylation and
degradation of IκBα at earlier time periods (2–15min)
(Figure 10(a)),andthedegradationandrecoveryofIκBαand
IκBβ at 0.5–2h (Figure 10(b)). Alternative signal pathway in
iNOS induction is the upregulation of type 1 IL-1 receptorJournal of Nutrition and Metabolism 7
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Figure 9: Eﬀects of peroxidized EPA/DHA on the activation of NF-κB. Cells were treated with IL-1β (1nM) in the presence or absence of
peroxidized EPA for 3 days and DHA for 1.5 days (each, 500μM) for the indicated times. Nuclear extracts (4μgo fp r o t e i n )w e r ea n a l y z e db y
EMSA.
(IL-1RI) through the activation of phosphatidylinositol 3-
kinase (PI3K)/Akt[31]. Peroxidized EPA/DHA had no eﬀect
on the expression of IL-1R I protein (data not shown).
iNOS mRNA is regulated by iNOS promoter transacti-
vation (mRNA synthesis) through NF-κBa c t i v a t i o na n db y
posttranscriptional modiﬁcations such as mRNA stabiliza-
tion [32]. We have recently reported the expression of an
iNOS gene antisense transcript that interacts with the 3 -
UTR containing AU-rich elements (AREs) of iNOS mRNA
and its ARE-binding proteins, thereby leading to iNOS
mRNAstabilizationincytokine-stimulatedhepatocytes[33].
Experiments with strand-speciﬁc RT-PCR revealed that IL-
1β increased the expression of the iNOS gene antisense
transcript in a time-dependent manner, and peroxidized
EPA/DHA reduced the levels of the antisense transcript
expression (Figures 11(a) and 11(b)).
4.Discussion
In the present study, we found that peroxidized products of
EPA/DHA,butnot of unoxidized EPA/DHA,inhibited iNOS
induction, followed by the reduction of NO production in
proinﬂammatory cytokine-stimulated hepatocytes (Figures
2(a) and 2(b),a n d5). MDA itself did not inhibit NO
production. The inhibitory eﬀects on NO production by
peroxidizedEPA/DHAweredependentontheirperoxidation
levels (expressed as MDA equivalent) (Figure 4). Thus, it
seems likely that peroxidized products of EPA/DHA, but
not MDA, are involved in the inhibition of NO production.
P e r o x i d i z e dE P A / D H Am a r k e d l yi n h i b i t e di N O Sp r o t e i n
and its mRNA expression at earlier time periods, but less
eﬀectively thereafter (Figures 7 and 8). This observation is
probably in part because of the reduction of peroxidized
products by oxidoreductases such as super oxide dismutase
in hepatocytes.
It is known that the induction of iNOS gene expression
is regulated by the iNOS promoter transactivation and post-
transcriptional modiﬁcations [32]. EMSA revealed that per-
oxidized EPA/DHA inhibited NF-κBa c t i v a t i o n( Figure 9).
NF-κB typically exists in the form of p50/65 heterodimers
attached to its inhibitory proteins (IκBs, IκBα,a n dI κBβ)
in the cytoplasm of cells. The activation of NF-κBi n v o l v e s
(i) proteolytic degradation of IκBs in proteasome after the
phosphorylation by IκB kinase, (ii) the translocation of NF-
κB to the nucleus, and (iii) its binding to the promoter κB
site [16]. However, peroxidized EPA/DHA did not aﬀect the
phosphorylation ofIκBα(Figure 10(a)),and thedegradation
and recovery of IκBα and IκBβ (Figure 10(b)).
We previously found that the upregulation of IL-1RI
through the activation of PI3K/Akt is essential for iNOS
induction in addition to IκB/NF-κBp a t h w a y[ 31]. However,
peroxidized EPA/DHA had no eﬀect on the upregulation of8 Journal of Nutrition and Metabolism
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Figure 10: Eﬀects of peroxidized EPA/DHA on the phosphorylation and degradation of IκB proteins. Cells were treated with IL-1β (1nM)
in the presence or absence of peroxidized EPA for 3 days and DHA for 1.5 days (each, 500μM) for the indicated times. (a) Phosphorylation
and degradation of IκBα, and (b) degradation and recovery of IκBα and IκBβ. Cell lysates (25μg of protein) were subjected to SDS-PAGE in
a 12.5% gel, followed by immunoblotting with an anti-phospho-IκBα,a n t i - I κBα or anti-IκBβ antibody.
IL-1RI protein, although they tended to reduce the levels
of IL-1RI mRNA expression (data not shown). Thus, the
inhibitory eﬀect of peroxidized EPA/DHA is presumably
NF-κB-dependent but IL-1RI-independent mechanism. The
inhibitory eﬀect of DHA on iNOS induction seems to be
superior than that of EPA due to a higher susceptibility of
DHA to peroxidation.
Regarding the posttranscriptional modiﬁcations, the 3 -
UTR of the iNOS mRNA in rats has six AREs (AUUU(U)A),
which areassociated with ARE-bindingproteinssuch asHuR
and heterogeneous nuclear ribonucleoproteins L/I (PTB),
thus contributing to the stabilization of the mRNA [34].
Recently, we found that the antisense strand corresponding
to the 3 -UTR of iNOS mRNA is transcribed from the
iNOS gene, and that the iNOS mRNA antisense-transcript
plays a key role in stabilizing the iNOS mRNA by inter-
acting with the 3 -UTR- and ARE-binding proteins [33].
Peroxidized EPA/DHA reduced the levels of the antisense-
transcript expression (Figures 11(a) and 11(b)). Taken
together,peroxidizedn-3PUFAsincludingEPA/DHAinhibit
NF-κB activation and iNOS antisense transcript expression,
leading to the blockades of iNOS mRNA synthesis and
its stabilization, resulting in the suppression of iNOS gene
induction.
When we orally take n-3 PUFA-containing foods, such
as grilled or boiled ﬁsh, peroxidized products of n-3 PUFAs
are signiﬁcant levels in human serum [8, 28] as similar
as those used in this study. Although we agree with the
common view that lipid peroxidized productsare considered
harmful to living body, it cannot negate the possibility that
peroxidized products as well as n-3 PUFAs themselves have a
varietyofbiologicalactivities, suchasanti-inﬂammatory and
anticancer eﬀects.
As mentioned before, Sethi et al. reported that anti-
inﬂammatory eﬀects of n-3 PUFAs were due to their per-
oxidized products [6, 7] .P e r o x i d i z e dE P Ai n h i b i t e dN F - κB
activation through PPARα activation using PPARα knockout
mice [28] and also inhibited the expression of chemokines in
cytokine-stimulated endothelial cells through the inhibition
of NF-κB activation via PPARα-dependent pathway but notJournal of Nutrition and Metabolism 9
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Figure 11:Eﬀects ofperoxidized EPA/DHA onthe expression ofthe iNOS gene antisense transcript. Cells were treated with IL-1β (1nM) in
the presence or absence of peroxidized EPA for 3 days (a) and DHA for 1.5 days (b) (each, 500μM) for the indicated times. Total RNA was
analyzed by strand-speciﬁc RT-PCR to detect the iNOS gene antisense transcript (iNOS-AST). RT(−): a negative control PCR using total
RNA without RT.
viathephosphorylation anddegradation ofIκBα[9].Similar
with these observations, peroxidized EPA/DHA inhibited
NF-κB activation not via phosphorylation and degradation
of IκBα in our IL-1β-stimulated hepatocytes, while a partici-
pation of PPARα remains unclear in the present study.
Accumulating evidence indicates that NO and iNOS
are concerned with cancer development. There are many
reports that NO can promote cancer development through
inductionofDNAdamage,increasedangiogenesisandblood
ﬂow, prevention of apoptotic cell death, and suppression
of the immune system, although there are reports that NO
can suppress cancer development [35, 36]. The anticancer
eﬀect of PUFAs, including our previous reports, may be in
part due to NO suppression by peroxidized products of the
PUFAs. Further investigation is needed to examine whether
NO suppression by peroxidized n-3 PUFAs contributes to
anticancer eﬀect.
In conclusion, peroxidized products of n-3 PUFAs sup-
press iNOS induction and NO production in peroxidation-
dependent manners. Results suggest that peroxidized prod-
ucts of n-3 PUFAs are in part involved in the anti-
inﬂammatory eﬀects.Further, theequationfrom the correla-
tionbetweenperoxidationlevelandNOsuppressionsuggests
that our in vitro NO production model in hepatocytes
may be a candidate for biological quantiﬁcation of lipid
peroxidation.
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